Quest Diagnostics Incorporated Stock Analysis
DGX Stock | USD 130.09 1.65 1.28% |
Quest Diagnostics Incorporated is undervalued with Real Value of 136.5 and Target Price of 146.31. The main objective of Quest Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Quest Diagnostics Incorporated is worth, separate from its market price. There are two main types of Quest Diagnostics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Quest Diagnostics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Quest Diagnostics' stock to identify patterns and trends that may indicate its future price movements.
The Quest Diagnostics stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Quest Diagnostics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Quest Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Quest Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
Quest |
Quest Stock Analysis Notes
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 56.82. The company has Price/Earnings To Growth (PEG) ratio of 1.52. Quest Diagnostics recorded earning per share (EPS) of 7.49. The entity last dividend was issued on the 5th of April 2024. The firm had 2:1 split on the 21st of June 2005. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Quest Diagnostics operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 50000 people. To learn more about Quest Diagnostics Incorporated call Stephen Rusckowski at 973 520 2700 or check out https://www.questdiagnostics.com.Quest Diagnostics Quarterly Total Revenue |
|
Quest Diagnostics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Quest Diagnostics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Quest Diagnostics Incorporated or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Quest Diagnostics has a strong financial position based on the latest SEC filings | |
Over 92.0% of the company shares are held by institutions such as insurance companies | |
On 22nd of April 2024 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders | |
Latest headline from seekingalpha.com: Quest Diagnostics Q1 2024 Earnings Preview |
Quest Diagnostics Upcoming and Recent Events
Earnings reports are used by Quest Diagnostics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Quest Diagnostics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
1st of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
1st of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Quest Largest EPS Surprises
Earnings surprises can significantly impact Quest Diagnostics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2000-04-24 | 2000-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2000-01-27 | 1999-12-31 | 0.05 | 0.06 | 0.01 | 20 | ||
1999-01-27 | 1998-12-31 | 0.04 | 0.05 | 0.01 | 25 |
Quest Diagnostics Thematic Classifications
In addition to having Quest Diagnostics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Quest Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Quest Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest Diagnostics Incorporated backward and forwards among themselves. Quest Diagnostics' institutional investor refers to the entity that pools money to purchase Quest Diagnostics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.9 M | Amvescap Plc. | 2023-12-31 | 1.7 M | Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 1.7 M | Wells Fargo & Co | 2023-12-31 | 1.5 M | Fmr Inc | 2023-12-31 | 1.3 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Bank Of America Corp | 2023-12-31 | 1 M | Legal & General Group Plc | 2023-12-31 | 1 M | Ameriprise Financial Inc | 2023-12-31 | 1 M | Vanguard Group Inc | 2023-12-31 | 13.6 M | Blackrock Inc | 2023-12-31 | 10.6 M |
Quest Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 14.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Quest Diagnostics's market, we take the total number of its shares issued and multiply it by Quest Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Quest Profitablity
Quest Diagnostics' profitability indicators refer to fundamental financial ratios that showcase Quest Diagnostics' ability to generate income relative to its revenue or operating costs. If, let's say, Quest Diagnostics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Quest Diagnostics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Quest Diagnostics' profitability requires more research than a typical breakdown of Quest Diagnostics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.13 %, which entails that for every 100 dollars of revenue, it generated $0.13 of operating income. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.17 | 0.14 | |
Return On Capital Employed | 0.11 | 0.10 | |
Return On Assets | 0.06 | 0.04 | |
Return On Equity | 0.14 | 0.08 |
Management Efficiency
Quest Diagnostics has Return on Asset of 0.0621 % which means that on every $100 spent on assets, it made $0.0621 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1462 %, implying that it generated $0.1462 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2024. Return On Capital Employed is likely to drop to 0.10 in 2024. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.99 in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 56.31 | 59.13 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | (22.15) | (23.26) | |
Enterprise Value Over EBITDA | 11.24 | 7.31 | |
Price Book Value Ratio | 2.45 | 3.00 | |
Enterprise Value Multiple | 11.24 | 7.31 | |
Price Fair Value | 2.45 | 3.00 | |
Enterprise Value | 9.7 B | 10.2 B |
The analysis of Quest Diagnostics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Quest Diagnostics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Quest Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0231 | Forward Dividend Yield 0.0231 | Forward Dividend Rate 3 | Beta 0.893 |
Technical Drivers
As of the 23rd of April, Quest Diagnostics holds the Variance of 1.28, risk adjusted performance of (0), and Coefficient Of Variation of (8,289). Quest Diagnostics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Quest Diagnostics, which can be compared to its competitors. Please check Quest Diagnostics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Quest Diagnostics is priced some-what accurately, providing market reflects its current price of 130.09 per share. Given that Quest Diagnostics has information ratio of (0.09), we recommend you to check out Quest Diagnostics's recent market performance to make sure the company can sustain itself at a future point.Quest Diagnostics Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Quest Diagnostics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Quest Diagnostics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Quest Diagnostics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Quest Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
John Ziegler over six months ago Sale by John Ziegler of 1953 shares of Quest Diagnostics |
Quest Diagnostics Outstanding Bonds
Quest Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Quest Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Quest bonds can be classified according to their maturity, which is the date when Quest Diagnostics Incorporated has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
QUEST DIAGNOSTICS INC Corp BondUS74834LAX82 | View | |
QUEST DIAGNOSTICS INC Corp BondUS74834LAV27 | View | |
QUEST DIAGNOSTICS INC Corp BondUS74834LAZ31 | View | |
US74834LAY65 Corp BondUS74834LAY65 | View | |
QUEST DIAGNOSTICS INCORPORATED Corp BondUS74834LBB53 | View | |
US74834LBA70 Corp BondUS74834LBA70 | View | |
US74834LBC37 Corp BondUS74834LBC37 | View |
Quest Diagnostics Predictive Daily Indicators
Quest Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Quest Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Quest Diagnostics Corporate Filings
8K | 23rd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
11th of April 2024 Other Reports | ViewVerify | |
5th of April 2024 Other Reports | ViewVerify | |
F4 | 3rd of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 28th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
25th of March 2024 Other Reports | ViewVerify | |
F4 | 1st of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 27th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Quest Diagnostics Forecast Models
Quest Diagnostics' time-series forecasting models are one of many Quest Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quest Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Quest Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Quest Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Quest shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Quest Diagnostics. By using and applying Quest Stock analysis, traders can create a robust methodology for identifying Quest entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.12 | 0.09 | |
Operating Profit Margin | 0.15 | 0.10 | |
Net Profit Margin | 0.09 | 0.05 | |
Gross Profit Margin | 0.32 | 0.44 |
Current Quest Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Quest analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Quest analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
146.31 | Buy | 17 | Odds |
Most Quest analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Quest stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Quest Diagnostics, talking to its executives and customers, or listening to Quest conference calls.
Quest Stock Analysis Indicators
Quest Diagnostics Incorporated stock analysis indicators help investors evaluate how Quest Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Quest Diagnostics shares will generate the highest return on investment. By understating and applying Quest Diagnostics stock analysis, traders can identify Quest Diagnostics position entry and exit signals to maximize returns.
Begin Period Cash Flow | 315 M | |
Long Term Debt | 4.4 B | |
Common Stock Shares Outstanding | 113 M | |
Total Stockholder Equity | 6.3 B | |
Tax Provision | 204 M | |
Quarterly Earnings Growth Y O Y | 0.868 | |
Property Plant And Equipment Net | 2.4 B | |
Cash And Short Term Investments | 686 M | |
Cash | 686 M | |
Accounts Payable | 1.4 B | |
Net Debt | 4.7 B | |
50 Day M A | 128.3122 | |
Total Current Liabilities | 1.8 B | |
Other Operating Expenses | 8 B | |
Non Current Assets Total | 11.7 B | |
Forward Price Earnings | 14.6199 | |
Non Currrent Assets Other | 198 M | |
Stock Based Compensation | 77 M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.868 | Dividend Share 2.84 | Earnings Share 7.49 | Revenue Per Share 82.607 | Quarterly Revenue Growth (0.02) |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.